Stock Analysis
- China
- /
- Healthcare Services
- /
- SZSE:002044
Discovering 7Road Holdings And Two Other Promising Penny Stocks
Reviewed by Simply Wall St
As global markets navigate choppy waters, with U.S. equities experiencing declines and small-cap stocks underperforming, investors are seeking opportunities that might offer growth potential amid uncertainty. Penny stocks, though an older term, continue to represent a compelling investment area for those looking to explore beyond the mainstream market. These smaller or newer companies can offer significant upside when backed by strong financials and solid fundamentals, providing a chance to uncover hidden value in quality investments.
Top 10 Penny Stocks
Name | Share Price | Market Cap | Financial Health Rating |
Polar Capital Holdings (AIM:POLR) | £4.805 | £463.19M | ★★★★★★ |
DXN Holdings Bhd (KLSE:DXN) | MYR0.50 | MYR2.64B | ★★★★★★ |
Embark Early Education (ASX:EVO) | A$0.775 | A$142.2M | ★★★★☆☆ |
ME Group International (LSE:MEGP) | £1.898 | £715.19M | ★★★★★★ |
Foresight Group Holdings (LSE:FSG) | £3.61 | £413.58M | ★★★★★★ |
LaserBond (ASX:LBL) | A$0.575 | A$66.82M | ★★★★★★ |
Hil Industries Berhad (KLSE:HIL) | MYR0.885 | MYR297.09M | ★★★★★★ |
Lever Style (SEHK:1346) | HK$0.86 | HK$545.92M | ★★★★★★ |
Starflex (SET:SFLEX) | THB2.60 | THB2.08B | ★★★★☆☆ |
Secure Trust Bank (LSE:STB) | £3.49 | £66.56M | ★★★★☆☆ |
Click here to see the full list of 5,815 stocks from our Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
7Road Holdings (SEHK:797)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: 7Road Holdings Limited is an investment holding company that develops and distributes web and mobile games in the People’s Republic of China and internationally, with a market cap of HK$2.81 billion.
Operations: The company generates revenue primarily from its Computer Graphics segment, amounting to CN¥400.16 million.
Market Cap: HK$2.81B
7Road Holdings Limited, with a market cap of HK$2.81 billion, is focused on web and mobile game development. Despite being unprofitable, it has managed to reduce its losses over the past five years by 1.4% annually and maintains a strong balance sheet with no debt. Its short-term assets of CN¥344.5 million comfortably cover both short-term (CN¥115 million) and long-term liabilities (CN¥13.7 million). Management stability is evident with an experienced team averaging 5.5 years in tenure. Recent changes include appointing ZHONGHUI ANDA CPA Limited as the new auditor following Elite Partners' resignation due to regulatory issues in China.
- Navigate through the intricacies of 7Road Holdings with our comprehensive balance sheet health report here.
- Review our historical performance report to gain insights into 7Road Holdings' track record.
Meinian Onehealth Healthcare Holdings (SZSE:002044)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Meinian Onehealth Healthcare Holdings Co., Ltd. operates in the healthcare industry, providing health examination and medical services, with a market cap of CN¥16.30 billion.
Operations: The company generates revenue primarily from the medical industry, amounting to CN¥10.73 billion.
Market Cap: CN¥16.3B
Meinian Onehealth Healthcare Holdings, with a market cap of CN¥16.30 billion, reported revenue of CN¥7.14 billion for the first nine months of 2024, slightly down from the previous year. Despite this dip, earnings growth has been impressive over the past year and is forecast to continue growing robustly. The company's debt management has improved significantly; its net debt to equity ratio stands at a satisfactory 27.9%, supported by strong operating cash flow coverage (39.8%). However, short-term liabilities exceed short-term assets by CN¥2 billion, indicating potential liquidity challenges that investors should monitor closely.
- Jump into the full analysis health report here for a deeper understanding of Meinian Onehealth Healthcare Holdings.
- Evaluate Meinian Onehealth Healthcare Holdings' prospects by accessing our earnings growth report.
Cosmos Group (SZSE:002133)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Cosmos Group Co., Ltd. operates in the real estate development sector in China with a market capitalization of CN¥1.79 billion.
Operations: The company's revenue segment is derived entirely from China, amounting to CN¥5.13 billion.
Market Cap: CN¥1.79B
Cosmos Group Co., Ltd. operates in the real estate sector with a market capitalization of CN¥1.79 billion and has faced challenges recently, reporting a net loss of CN¥152.06 million for the first nine months of 2024, down from a net income the previous year. The company's revenue fell significantly to CN¥3.35 billion from CN¥7.46 billion year-over-year, highlighting operational difficulties amid declining sales and profitability issues. Despite being unprofitable, Cosmos maintains satisfactory debt management with short-term assets exceeding liabilities and no significant shareholder dilution recently, suggesting some financial stability amidst its current challenges in the volatile penny stock landscape.
- Click here to discover the nuances of Cosmos Group with our detailed analytical financial health report.
- Understand Cosmos Group's track record by examining our performance history report.
Taking Advantage
- Reveal the 5,815 hidden gems among our Penny Stocks screener with a single click here.
- Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Jump on the AI train with fast growing tech companies forging a new era of innovation.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:002044
Meinian Onehealth Healthcare Holdings
Meinian Onehealth Healthcare Holdings Co., Ltd.